Stock comparison
Halozyme Therapeutics
Intuitive Surgical
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
HALO
Halozyme Therapeutics
Market cap
$8.13B
Sector
Healthcare
ISRG
Intuitive Surgical
Market cap
$155.76B
Sector
Healthcare
Overall winner
Intuitive Surgical ISRG
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | HALO | ISRG | Winner |
|---|---|---|---|
| Warren Buffett | 79B | 64C | HALO |
| Benjamin Graham | 83A | 89A | ISRG |
| Philip Fisher | 65B | 79B | ISRG |
| Peter Lynch | 53D | 76B | ISRG |
| Joel Greenblatt | 40D | 61C | ISRG |
| Charlie Munger | 80C | 69B | HALO |
| Terry Smith | 84A | 66B | HALO |
Side-by-side metrics
| Metric | HALO | ISRG |
|---|---|---|
| Market cap | $8.13B | $155.76B |
| P/E (TTM) | 24.0x | 50.2x |
| EV/EBIT | 10.2x | 49.9x |
| ROIC (TTM) | 23.65% | 16.49% |
| Gross margin | 81.24% | 66.29% |
| Net margin | 23.13% | 28.15% |
| Revenue CAGR 5y | 33.23% | 15.22% |
| EPS CAGR 5y | -1.98% | 13.68% |
| Debt / Equity | 1.0x | - |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
HALO leads on
- EV/EBIT10.2xvs 49.9x+80%
- Revenue CAGR 5y33.23%vs 15.22%+54%
- P/E (TTM)24.0xvs 50.2x+52%
- ROIC (TTM)23.65%vs 16.49%+30%
ISRG leads on
- EPS CAGR 5y13.68%vs -1.98%+114%
- Debt / Equity-vs 1.0x+100%
- Market cap$155.76Bvs $8.13B+95%
- Net margin28.15%vs 23.13%+18%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.